Research map: “Yong” syndrome–cGAS-STING axis: a TCM syndrome-based hypothesis for overcoming primary anti-PD-1 resistance in gastric cancer

Back to the article

Papers in this map

  1. Gastric cancer · Elizabeth Catherine Smyth · 2020 · 5032 citations · Cited by this paper
  2. TGF-β1 drives neutrophil extracellular traps formation to promote CD8 + T cell exhaustion via the ERK-c-Fos-JunB axis, mediating gastric cancer immunotherapy resistance · 2026 · Related
  3. Evaluation of efficacy, safety and underlying mechanism on Traditional Chinese medicine as synergistic agents for cancer immunotherapy: A preclinical systematic review and meta-analysis · Jing Li · 2024 · 26 citations · Cited by this paper
  4. Pharmacologic activity, safety, and preliminary efficacy of GEN3009, a CD37-targeting DuoHexaBody, in relapsed or refractory B-cell non-Hodgkin’s lymphoma · 2026 · Related
  5. Tanshinone IIA Reverses the Malignant Phenotype of SGC7901 Gastric Cancer Cells · Min Xu · 2013 · 22 citations · Cited by this paper
  6. Safety and efficacy of fecal microbiota transplantation in solid cancers resistant to immune checkpoint inhibitors: results of the MITRIC trial · 2026 · Related
  7. Outcomes and a prognostic classifier in patients with microsatellite instability-high metastatic gastric cancer receiving PD-1 blockade · Giovanni Randon · 2023 · 21 citations · Cited by this paper
  8. Circumventing Ewing sarcoma tumor microenvironment resistance by IL1RAP CAR-modified TGFβ1-imprinted natural killer cells in combination with IL-15 agonist and anti-GD2 antibody · 2026 · Related
  9. High levels of tumor cell-intrinsic STING signaling are associated with increased infiltration of CD8+ T cells in dMMR/MSI-H gastric cancer · Ryo Kanoda · 2024 · 14 citations · Cited by this paper
  10. HDAC inhibitors reverse YAP-driven immune resistance in NSCLC: mechanistic and translational evidence · 2026 · Related
  11. cGAS-STING pathway as a promising target for digestive diseases: insights from natural plant products · Dan Long · 2025 · 7 citations · Cited by this paper
  12. Efficient discovery of an agonistic anti-OX40 nanobody by epitope-directed approach to address enrichment-driven epitope bias · 2026 · Related
  13. Cancer cell-extrinsic STING shapes immune-active microenvironment and predicts clinical outcome in gastric cancer · Wei Ye · 2024 · 3 citations · Cited by this paper
  14. Systemic immune profiling in hepatocellular carcinoma: navigating etiological heterogeneity and selection bias · 2026 · Related
  15. Personalized tumor-loaded monocyte-derived dendritic cell vaccination in combination with atezolizumab as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): phase Ib-II VENEZOLUNG trial · 2026 · Related
  16. In situ generation of proinflammatory CAR macrophages via mRNA-TLR agonist co-delivery for triple-negative breast cancer immunotherapy · 2026 · Related
  17. Guarding epithelial integrity: origins of adaptive immunity and cancer immunosurveillance over time and space · 2026 · Related

Source: OpenAlex (CC0)